P

Inventor

ATWAL KARNAIL S

US33 patents
⚠️ This page may combine multiple inventors who share the name “ATWAL KARNAIL S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

25 patents
US7157451B2Jan 2, 2007

Heterocyclic dihydropyrimidine compounds

BRISTOL MYERS SQUIBB CO70 citations97
US5547966AAug 20, 1996

Aryl urea and related compounds

BRISTOL MYERS SQUIBB CO125 citations97
US6916813B2Jul 12, 2005

(1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase

BRISTOL MYERS SQUIBB CO80 citations96
US6887870B1May 3, 2005

Heterocyclic sodium/proton exchange inhibitors and method

BRISTOL MYERS SQUIBB CO51 citations95
US6706720B2Mar 16, 2004

Heterocyclic dihydropyrimidine compounds

BRISTOL MYERS SQUIBB CO60 citations95
US6511977B1Jan 28, 2003

Potassium channel inhibitors and method

BRISTOL MYERS SQUIBB CO46 citations95
US6150356ANov 21, 2000

Potassium channel inhibitors and method

BRISTOL MYERS SQUIBB CO73 citations95
US5869478AFeb 9, 1999

Sulfonamido substituted benzopyran derivatives

BRISTOL MYERS SQUIBB CO45 citations93
US7326705B2Feb 5, 2008

Heterocyclic sodium/proton exchange inhibitors and method

BRISTOL MYERS SQUIBB CO24 citations92
US6664250B2Dec 16, 2003

Lactam derivatives as antiarrhythmic agents

BRISTOL MYERS SQUIBB CO30 citations92
US6624309B1Sep 23, 2003

Benzoic acid derivatives and related compounds as antiarrhythmic agents

BRISTOL MYERS SQUIBB CO33 citations92
US6262068B1Jul 17, 2001

Lactam derivatives as antiarrhythmic agents

BRISTOL MYERS SQUIBB CO49 citations92
US5837702ANov 17, 1998

4-arylamino-benzopyran and related compounds

BRISTOL MYERS SQUIBB CO25 citations92
US5612370AMar 18, 1997

Phenylglycine and phenylalaninen amido benzopyran derivatives

BRISTOL MYERS SQUIBB CO25 citations92
US5401758AMar 28, 1995

Pyridinyl cyanoguanidine compounds

BRISTOL MYERS SQUIBB CO52 citations92
US6048877AApr 11, 2000

Tetralone derivatives as antiarrhythmic agents

BRISTOL MYERS SQUIBB CO16 citations84
US6011059AJan 4, 2000

Acyl guanidine sodium/proton exchange inhibitors and method

BRISTOL MYERS SQUIBB CO14 citations74
US6881753B2Apr 19, 2005

Potassium channel inhibitors and method

BRISTOL MYERS SQUIBB CO10 citations73
US6784189B2Aug 31, 2004

Potassium channel inhibitors and method

BRISTOL MYERS SQUIBB CO5 citations73
US6160134ADec 12, 2000

Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines

BRISTOL MYERS SQUIBB CO8 citations71
US6458835B2Oct 1, 2002

Method of inhibiting or treating chemotherapy-induced hair loss

BRISTOL MYERS SQUIBB CO5 citations63
US6013668AJan 11, 2000

Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile

BRISTOL MYERS SQUIBB CO1 citations63
US7541362B2Jun 2, 2009

Heterocyclic dihydropyrimidine compounds

BRISTOL MYERS SQUIBB CO1 citations62
US6472427B1Oct 29, 2002

Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile

BRISTOL MYERS SQUIBB CO0 citations52
US6262122B1Jul 17, 2001

Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile

BRISTOL MYERS SQUIBB CO0 citations48

SQUIBB & SONS INC

6 patents

BRISOL MYERS SQUIBB COMPANY

1 patent

REDPOINT BIO CORP

1 patent